Literature DB >> 15026513

Concurrent hereditary haemochromatosis and idiopathic Parkinson's disease: a case report series.

D J Costello1, S L Walsh, H J Harrington, C H Walsh.   

Abstract

Hereditary haemochromatosis (HH) is a genetic disorder in which abnormal iron handling leads to excessive iron accumulation in systemic tissues. Magnetic resonance imaging studies suggest excess iron deposition in the basal ganglia of patients with HH. The symptoms of neurological complications of HH include cognitive decline, gait difficulties, cerebellar ataxia, and extrapyramidal dysfunction, but idiopathic Parkinson's disease, in which brain iron deposition is normal, has not been reported. We describe four patients with concurrent HH and IPD. Although three of the cases had risk factors for cerebrovascular and cardiovascular disease, computed tomography did not show ischaemic changes in the basal ganglia. We speculate that in these cases, abnormal deposition of iron in the basal ganglia induced the symptoms of IPD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026513      PMCID: PMC1739011          DOI: 10.1136/jnnp.2003.027441

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  Iron-mediated retinal degeneration in haemojuvelin-knockout mice.

Authors:  Jaya P Gnana-Prakasam; Amany Tawfik; Michelle Romej; Sudha Ananth; Pamela M Martin; Sylvia B Smith; Vadivel Ganapathy
Journal:  Biochem J       Date:  2012-01-15       Impact factor: 3.857

2.  Hereditary hemochromatosis and movement disorders: the still controversial relationship. Response to Russo et al. in J Neurol (2004) 251:849-852.

Authors:  G Demarquay; S Thobois; P Latour; Emmanuel Broussolle
Journal:  J Neurol       Date:  2005-08-17       Impact factor: 4.849

3.  Chronic cerebellar ataxia and hereditary hemochromatosis: causal or coincidental association?

Authors:  M P Rutgers; A Pielen; M Gille
Journal:  J Neurol       Date:  2007-04-21       Impact factor: 4.849

4.  Movement disorder due to aceruloplasminemia and incorrect diagnosis of hereditary hemochromatosis.

Authors:  Alfonso Fasano; Anna Rita Bentivoglio; Cesare Colosimo
Journal:  J Neurol       Date:  2007-02-14       Impact factor: 4.849

5.  A parkinsonian movement disorder with brain iron deposition and a haemochromatosis mutation.

Authors:  Stefan Williams; Maruthi Ravi Vinjam; Azzam Ismail; Ahamad Hassan
Journal:  J Neurol       Date:  2013-06-23       Impact factor: 4.849

6.  A young patient with type C multiple system atrophy and hereditary hemochromatosis.

Authors:  Massimiliano Di Filippo; Piero Floridi; Vera Rossi; Emanuele Mattucci; Aroldo Rossi; Paolo Calabresi; Nicola Tambasco
Journal:  J Neurol       Date:  2009-10-14       Impact factor: 4.849

7.  Prevalence of haemochromatosis gene mutations in Parkinson's disease.

Authors:  Anne Hege Aamodt; Lars Jacob Stovner; Ketil Thorstensen; Stian Lydersen; Linda R White; Jan O Aasly
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10-20       Impact factor: 10.154

8.  Dynamics of tyrosine hydroxylase mediated regulation of dopamine synthesis.

Authors:  Poorvi Kaushik; Fredric Gorin; Shireen Vali
Journal:  J Comput Neurosci       Date:  2007-04       Impact factor: 1.621

Review 9.  Parkinsonism and inborn errors of metabolism.

Authors:  A Garcia-Cazorla; S T Duarte
Journal:  J Inherit Metab Dis       Date:  2014-06-07       Impact factor: 4.982

10.  Absence of iron-regulatory protein Hfe results in hyperproliferation of retinal pigment epithelium: role of cystine/glutamate exchanger.

Authors:  Jaya P Gnana-Prakasam; Muthusamy Thangaraju; Kebin Liu; Yonju Ha; Pamela M Martin; Sylvia B Smith; Vadivel Ganapathy
Journal:  Biochem J       Date:  2009-11-11       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.